Interferon-α Prevents Leukemia Relapse of AML Patients After Transplantation

Clinical trial NCT03121079 · WITHDRAWN

Trial details

NCT number: NCT03121079
Sponsor: Peking University People's Hospital
Status: WITHDRAWN
Phase: Not Applicable
Study type: INTERVENTIONAL

Interferon-A-2B Relapse Prevention Hematopietic Stem Cell Transplantation

Start date: 2017-05-01
Primary completion: 2019-12-31
Enrollment: 0

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.